0001570562-24-000005.txt : 20240202
0001570562-24-000005.hdr.sgml : 20240202
20240202165732
ACCESSION NUMBER: 0001570562-24-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240130
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parschauer Karah Herdman
CENTRAL INDEX KEY: 0001677455
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38381
FILM NUMBER: 24592444
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolus, Inc.
CENTRAL INDEX KEY: 0001570562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 461385614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: (949) 284-4555
MAIL ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
4
1
wk-form4_1706911039.xml
FORM 4
X0508
4
2024-01-30
0
0001570562
Evolus, Inc.
EOLS
0001677455
Parschauer Karah Herdman
520 NEWPORT CENTER DRIVE
SUITE 1200
NEWPORT BEACH
CA
92660
1
0
0
0
1
Common Stock
2024-01-30
4
S
0
11931
13.1366
D
31243
D
The shares were sold in multiple trades at prices ranging from $13.025 to $13.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares sold pursuant to a 10b5-1 plan adopted in August 2023.
/s/ Jeffrey J. Plumer, as attorney-in-fact for Karah Parschauer
2024-02-02